Skip to main content
. Author manuscript; available in PMC: 2015 Jan 5.
Published in final edited form as: Radiother Oncol. 2008 Nov 27;90(2):183–188. doi: 10.1016/j.radonc.2008.10.020

Figure 2.

Figure 2

Figure 2a. Local Recurrence in p53 Negative Patients: The 10-year LR-free survival was 68% for BCCIP-positive tumors (n = 17) and 46% for BCCIP-negative tumors (n = 13); (p = 0.04, log-rank test).

Figure 2b. Local Recurrence in p53-Positive Patients: The 10-year LR-free survival was 75% for BCCIP-positive tumors (n = 35) and 80% for BCCIP-negative tumors (n = 28); (p = 0.54, log-rank test).